CECORS (CEOS) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 122 196 sessions, October 23, 2025 to October 26, 2026
- Largest daily move
- +115.4% close of March 31, 2026
- 1-year change
- +37.5% closing prices, October 23, 2025 to October 26, 2026
- 1-month change
- +34.1% closing prices, September 25, 2026 to October 26, 2026
Company Description
CECORS (OTC: CEOS) is classified in the medical instruments & supplies industry within the Healthcare sector and carries a market capitalization of $1.8M.
CEOS has gained 37.5% over the past year. The last closing price was $0.0055.
This page collects what Stock Titan holds for CEOS, including price data, latest news, and short interest trends.
Stock Performance
CECORS (CEOS) closed at $0.0055 on October 26, 2026. Over the past 12 months, the price has gained 37.5%.
CEOS Metrics & Rankings
Price returns through October 26, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CECORS has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include partnership. View all CEOS news →
SEC Filings
Short Interest History
Short interest in CECORS (CEOS) currently stands at 2.4 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for CECORS (CEOS) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
CEOS Company Profile & Sector Positioning
CECORS (CEOS) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CEOS often look at related companies in the same sector, including CARDIAC BIOTECH SOLUTION (CBSC), REFLECT SCIENTIFIC INC (RSCF), ENCISION INC (ECIA), WEARABLE HEALTH SOLUTIONS (WHSI), and UNITED HEALTH PRODUTS INC (UEEC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CEOS's relative position within its industry.